🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 19 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 23/08/2002 | 32,98 | 33,05 | 28,90 | 30,32 | -6,14% | 12,60% | 226.183 |
| 22/08/2002 | 29,38 | 33,80 | 28,82 | 32,30 | +11,50% | 16,94% | 220.145 |
| 21/08/2002 | 29,57 | 29,94 | 28,33 | 28,97 | -0,39% | 5,44% | 171.254 |
| 20/08/2002 | 26,95 | 29,57 | 26,65 | 29,08 | +9,28% | 10,83% | 157.735 |
| 19/08/2002 | 26,95 | 27,89 | 26,43 | 26,61 | +0,14% | 5,42% | 131.125 |
| 16/08/2002 | 26,50 | 27,36 | 26,05 | 26,58 | +1,00% | 4,94% | 281.968 |
| 15/08/2002 | 26,50 | 26,87 | 26,13 | 26,31 | +1,15% | 2,82% | 287.311 |
| 14/08/2002 | 28,22 | 28,82 | 25,98 | 26,01 | -13,13% | 10,08% | 496.289 |
| 13/08/2002 | 33,50 | 33,50 | 29,57 | 29,94 | -11,89% | 11,73% | 147.129 |
| 12/08/2002 | 33,31 | 34,36 | 32,26 | 33,99 | +2,60% | 6,29% | 95.298 |
| 09/08/2002 | 33,87 | 35,03 | 32,23 | 33,13 | -3,17% | 8,29% | 78.921 |
| 08/08/2002 | 31,93 | 34,40 | 31,63 | 34,21 | +6,53% | 8,68% | 84.825 |
| 07/08/2002 | 33,05 | 35,30 | 30,43 | 32,11 | -2,28% | 14,72% | 99.680 |
| 06/08/2002 | 30,17 | 32,94 | 29,94 | 32,86 | +9,75% | 9,93% | 58.857 |
| 05/08/2002 | 31,44 | 32,26 | 29,79 | 29,94 | -4,76% | 7,86% | 103.928 |
| 02/08/2002 | 32,08 | 32,94 | 30,21 | 31,44 | -2,33% | 8,52% | 85.093 |
| 01/08/2002 | 33,46 | 34,62 | 31,85 | 32,19 | -4,02% | 8,28% | 160.140 |
| 31/07/2002 | 34,21 | 34,66 | 32,75 | 33,54 | -0,99% | 5,58% | 150.281 |
| 30/07/2002 | 31,74 | 35,90 | 30,77 | 33,87 | +6,47% | 16,16% | 322.363 |
| 29/07/2002 | 30,32 | 32,34 | 30,13 | 31,82 | +5,59% | 7,28% | 271.014 |
| 26/07/2002 | 29,05 | 30,32 | 28,90 | 30,13 | +1,77% | 4,90% | 189.902 |
| 25/07/2002 | 29,42 | 30,32 | 29,05 | 29,61 | -2,35% | 4,33% | 184.425 |
| 24/07/2002 | 28,18 | 30,58 | 27,89 | 30,32 | +7,57% | 9,56% | 150.602 |
| 23/07/2002 | 28,63 | 29,61 | 28,15 | 28,18 | -1,57% | 5,10% | 201.711 |
| 22/07/2002 | 28,45 | 29,94 | 28,03 | 28,63 | +0,66% | 6,71% | 141.251 |
| 19/07/2002 | 29,01 | 29,08 | 27,51 | 28,45 | -1,43% | 5,42% | 180.257 |
| 18/07/2002 | 29,68 | 29,76 | 26,46 | 28,86 | -1,53% | 11,10% | 309.058 |
| 17/07/2002 | 27,89 | 31,33 | 27,70 | 29,31 | +11,86% | 13,02% | 396.609 |
| 16/07/2002 | 24,74 | 28,71 | 23,81 | 26,20 | +5,90% | 19,82% | 483.946 |
| 15/07/2002 | 26,99 | 27,02 | 23,24 | 24,74 | -5,97% | 14,01% | 344.511 |